Study Title
A Multi-center, Open-label, Single Arm Phase III Clinical Trial for the Diagnostic Efficacy Assessment and Safety Evaluation by [18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer
Study Details
Description:
This is a multi-center, open-label, single arm Phase III clinical trial for the diagnostic efficacy assessment and safety evaluation by [18F]Florastamin PET/CT imaging examination to determine the presence of recurrent or metastatic prostate cancer in patients whose recurrent or metastatic lesions have been confirmed through the conventional imaging.
Sponsor:
FutureChem
Contacts:
Chan Soo Park, Ph.Dchansoo.park@futurechem.co.kr
+82-70-5066-2479
Government Study Link:
NCT05936658 - Click here to see study onClinicalTrials.gov